Short-term effect of oral treatment with miglustat in type 1 Gaucher disease.

被引:0
|
作者
Giraldo, P
Alonso, D
Acedo, M
Franco, R
Barez, A
Corrales, A
Serrano, D
Roldan, V
Latre, P
Alfonso, P
Pocovi, M
机构
[1] Miguel Servet Univ Hosp, Zaragoza, Spain
[2] Virgen Rocio Univ Hosp, Seville, Spain
[3] Vega Baja Hosp, Alicante, Spain
[4] Punta Europa Univ Hosp, Cadiz, Spain
[5] Ntra Sra Sansoles Hosp, Avila, Spain
[6] Virgen Concha Hosp, Zamora, Spain
[7] Gen Hosp, Alicante, Spain
[8] San Vicente Hosp, Alicante, Spain
[9] Spanish Fdn Study & Therapy Gaucher Dis, FEETEG, Zaragoza, Spain
[10] Inst Aragones Hlth Sci, I & CS, Zaragoza, Spain
[11] Univ Zaragoza, Zaragoza, Spain
关键词
D O I
10.1182/blood.V106.11.2235.2235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2235
引用
收藏
页码:629A / 630A
页数:2
相关论文
共 50 条
  • [1] Short-term effect of miglustat in every day clinical use in treatment-naive or previously treated patients with type 1 Gaucher's disease
    Giraldo, Pilar
    Latre, Paz
    Alfonso, Pilar
    Acedo, Antonio
    Alonso, Dora
    Barez, Abelardo
    Corrales, Alejandro
    Franco, Rafael
    Roldan, Vanessa
    Serrano, Sol
    Pocovi, Miguel
    HAEMATOLOGICA, 2006, 91 (05) : 703 - 706
  • [2] LONG TERM EFFICACY AND SAFETY OF MIGLUSTAT THERAPY IN TYPE 1 GAUCHER DISEASE. ZAGAL STUDY
    Giraldo, P.
    Latre, P.
    Acedo, A.
    Alonso, D.
    Barez, A.
    Martin, A.
    Franco, R.
    Fernandez-Villamot, A.
    Pocovi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 423 - 423
  • [3] Treatment by miglustat of an elderly patient with Gaucher's disease type 1
    de Roux-Serratrice, Christine
    Serratrice, Jacques
    Disdier, Patrick
    Weiller, Pierre-Jean
    PRESSE MEDICALE, 2006, 35 : S30 - S32
  • [4] Long term efficacy and safety of miglustat therapy in type 1 Gaucher disease
    Giraldo, M.
    Latre, P.
    Acedo, A.
    Alonso, D.
    Barez, A.
    Martin, A.
    Franco, R.
    Fernandez-Villamor, A.
    Pocovi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 279 - 279
  • [5] ADULT PATIENTS WITH TYPE I GAUCHER DISEASE (GD 1) ON LONG-TERM MIGLUSTAT TREATMENT
    Hollak, C.
    Heitner, R.
    Hrebicek, M.
    Elstein, D.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 171 - 171
  • [6] Treatment by miglustat of a young adult presenting type 1 Gaucher's disease
    Djerad, Hama
    PRESSE MEDICALE, 2006, 35 : S33 - S34
  • [7] Two-year oral miglustat in Gaucher disease type III
    Schiffmann, Raphael
    Chris, Harris
    Catherine, DeVile
    Elin, Davis-Pope
    Ed, Fitzgibbon
    Roscoe, Brady
    Larry, Abel
    Pauline, Campbell
    Ashok, Vellodi
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S33 - S33
  • [8] Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
    Giraldo, Pilar
    Andrade-Campos, Marcio
    Alfonso, Pilar
    Irun, Pilar
    Atutxa, Koldo
    Acedo, Antonio
    Barez, Abelardo
    Blanes, Margarita
    Diaz-Morant, Vicente
    Angeles Fernandez-Galan, Ma
    Franco, Rafael
    Gil-Cortes, Cristina
    Giner, Vicente
    Ibanez, Angela
    Latre, Paz
    Loyola, Ines
    Luno, Elisa
    Hernandez-Martin, Roberto
    Medrano-Engay, Blanca
    Puerta, Jose
    Roig, Inmaculada
    de la Serna, Javier
    Salamero, Olga
    Villalon, Lucia
    Pocovi, Miguel
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 173 - 179
  • [9] TEN YEARS OF EXPERIENCE WITH MIGLUSTAT IN TREATMENT OF TYPE 1 GAUCHER DISEASE: THE SPANISH ZAGAL PROJECT
    Giraldo, P.
    Andrade, M.
    Alfonso, P.
    Irun, P.
    Atucha, L.
    Acedo, A.
    Diaz-Morant, V.
    Barez, A.
    Fernandez-Galan, M.
    Franco, R.
    Giner, V.
    Loyola, I.
    Luno, E.
    de la Serna, J.
    Villalon, L.
    Salamero, O.
    Pocovi, M.
    HAEMATOLOGICA, 2014, 99 : 764 - 764
  • [10] Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
    Weinreb, NJ
    Barranger, JA
    Charrow, J
    Grabowski, GA
    Mankin, HJ
    Mistry, P
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) : 223 - 229